NBE THERAPEUTICS LLC has a total of 17 patent applications. Its first patent ever was published in 2012. It filed its patents most often in China, EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are SCIL PROTEINS GMBH, 4ANTIBODY AG and CHIMERA BIOENGINEERING INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Hong Kong | 1 | |
#8 | India | 1 | |
#9 | Japan | 1 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Microorganisms | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Medical preparations | |
#6 | Therapeutic chemical compounds | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Grawunder Ulf | 15 |
#2 | Beerli Roger Renzo | 3 |
#3 | Ulf Grawunder | 2 |
#4 | Roger Renzo Beerli | 1 |
Publication | Filing date | Title |
---|---|---|
EP2777714A1 | Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme | |
EP2692865A1 | Transposition-mediated identification of specific binding or functional proteins |